Sage Financial Management Group Inc. Makes New $229,000 Investment in The Procter & Gamble Company (NYSE:PG)

Sage Financial Management Group Inc. acquired a new position in shares of The Procter & Gamble Company (NYSE:PGFree Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,321 shares of the company’s stock, valued at approximately $229,000.

Several other large investors have also recently added to or reduced their stakes in the company. KMG Fiduciary Partners LLC grew its position in Procter & Gamble by 17.3% in the third quarter. KMG Fiduciary Partners LLC now owns 78,024 shares of the company’s stock valued at $13,514,000 after acquiring an additional 11,489 shares during the last quarter. Net Worth Advisory Group bought a new position in Procter & Gamble in the third quarter valued at about $729,000. Stratos Investment Management LLC grew its position in Procter & Gamble by 3.6% in the third quarter. Stratos Investment Management LLC now owns 36,733 shares of the company’s stock valued at $6,362,000 after acquiring an additional 1,290 shares during the last quarter. Richard W. Paul & Associates LLC grew its position in Procter & Gamble by 1.8% in the third quarter. Richard W. Paul & Associates LLC now owns 6,123 shares of the company’s stock valued at $1,061,000 after acquiring an additional 107 shares during the last quarter. Finally, Aspiriant LLC grew its position in Procter & Gamble by 6.0% in the third quarter. Aspiriant LLC now owns 30,566 shares of the company’s stock valued at $5,294,000 after acquiring an additional 1,743 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.6 %

NYSE PG opened at $171.28 on Friday. The company has a market cap of $404.23 billion, a price-to-earnings ratio of 28.45, a P/E/G ratio of 3.74 and a beta of 0.41. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The business has a 50 day moving average price of $171.77 and a 200-day moving average price of $167.11. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the company posted $1.83 earnings per share. The company’s quarterly revenue was down .6% on a year-over-year basis. As a group, equities analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.35%. Procter & Gamble’s dividend payout ratio (DPR) is currently 66.94%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Piper Sandler assumed coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Stifel Nicolaus lifted their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Evercore ISI lifted their price target on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Finally, BNP Paribas started coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $176.21.

View Our Latest Research Report on PG

Insider Buying and Selling

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.18% of the stock is owned by corporate insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.